PP214 – Human precision-cut lung slices generated from excess donor lungs as a model for IPF and drug screening

John Stegmayr, Sweden

Source: ERS Lung Science Conference 2021
Number: 82

E-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
John Stegmayr, Sweden. PP214 – Human precision-cut lung slices generated from excess donor lungs as a model for IPF and drug screening. ERS Lung Science Conference 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Small airway reactivity is not altered in precision-cut lung slices from a bleomycin mouse model of airway fibrosis
Source: International Congress 2018 – Basic pharmacology
Year: 2018

Comparison of distal lung innervation in human and guinea pig precision-cut lung slices (PCLS)
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011

Precision cut lung slices from bleomycin challenged mice – ex vivo model for testing novel therapies for lung fibrosis
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019

Three-dimensional tissue-based models for translational lung stem cell research: precision-cut lung slices
Source: Eur Respir Monogr 2021; 91: 222-231
Year: 2021


Relaxin potentiates ß2-adrenoceptor mediated bronchodilation in precision-cut lung slices (PCLS) from mouse models of airway inflammation and fibrosis, and in human airways
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

Evidence of increased pluripotent cells in adult human lung tissue derived from fibrotic lungs compared to non-fibrotic control lungs
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012


Human lung scaffolds to model lung disease and tissue regeneration
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018


Precision-cut lung slices as an in vitro model for testing of novel therapeutic agents
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020


Induction of pro-fibrotic biomarkers in precision-cut lung slices (PCLS)
Source: International Congress 2016 – IPF pathogenesis
Year: 2016

Characterisation of guinea pig precision-cut lung slices: comparison with human tissues
Source: Eur Respir J 2006; 28: 603-611
Year: 2006



Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro
Source: ERS Lung Science Conference 2018
Year: 2018

Cardiotonic agents affect pulmonary vessels in precision-cut lung slices (PCLS)
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011

Development of a porcine model to study donor lung injury
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009


Pro-fibrotic biomarkers in ex vivo lung tissue slices: A species comparison
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017

Progress towards human lung regeneration in end-stage respiratory failure: studying human lung development in vitro using organoid cultures of human embryonic lung stem cells
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018


Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011

Tissue distribution of inhalation drugs in rat lung slices
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015

Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and human donor lungs
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Sustained PAP-reduction and tissue cGMP-restoration without systemic NO-generation by aerosolized PAPA-NONOate in an isolated lung model of acute lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 561s
Year: 2004

Acellular human lung scaffolds to model lung disease and tissue regeneration
Source: Eur Respir Rev, 27 (148) 180021; 10.1183/16000617.0021-2018
Year: 2018